Exact Mass: 778.3928

Bis(glutathionyl)spermine disulfide

C30H54N10O10S2 (778.3466)

Dolichyl beta-D-glucuronosyl-(1->3)-beta-D-glucosyl phosphate

C37H63O15P (778.3904)

Vinorelbine

C45H54N4O8 (778.3941)

Vinorelbine is only found in individuals that have used or taken this drug. It is an anti-mitotic chemotherapy drug that is given as a treatment for some types of cancer, including breast cancer and non-small cell lung cancer. [Wikipedia]The antitumor activity of vinorelbine is thought to be due primarily to inhibition of mitosis at metaphase through its interaction with tubulin. Vinorelbine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death. Like other vinca alkaloids, vinorelbine may also interfere with: 1) amino acid, cyclic AMP, and glutathione metabolism, 2) calmodulin-dependent Ca²⁺-transport ATPase activity, 3) cellular respiration, and 4) nucleic acid and lipid biosynthesis. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CA - Vinca alkaloids and analogues C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids C1907 - Drug, Natural Product

Periandrin V

C41H62O14 (778.4139)

Periandrin V is a constituent of Periandra dulcis roots. Natural sweetener. Constituent of Periandra dulcis roots. Natural sweetener

Vinorelbine base

C45H54N4O8 (778.3941)

Vinorelbine

C45H54N4O8 (778.3941)

Vinorelbine is a vinca alkaloid with a norvinblastine skeleton. It has a role as an antineoplastic agent and a photosensitizing agent. It is a vinca alkaloid, an organic heteropentacyclic compound, an organic heterotetracyclic compound, a methyl ester, an acetate ester and a ring assembly. Vinorelbine is an anti-mitotic chemotherapy drug that is used in the treatment of several types of malignancies, including breast cancer and non-small cell lung cancer (NSCLC). It was initially approved in the USA in 1990s for the treatment of NSCLC. It is a third-generation vinca alkaloid. The introduction of third-generation drugs (vinorelbine, gemcitabine, taxanes) in platinum combination improved survival of patients with advanced NSCLC, with very similar results from the various drugs. Treatment toxicities are considerable in the combination treatment setting. A study was done on the clearance rate of vinorelbine on individuals with various single polymorphonuclear mutations. It was found that there was 4.3-fold variation in vinorelbine clearance across the cohort, suggesting a strong influence of genetics on the clearance of this drug. Vinorelbine is a Vinca Alkaloid. Vinorelbine is a semisynthetic vinca alkaloid. Vinorelbine binds to tubulin and prevents formation of the mitotic spindle, resulting in the arrest of tumor cell growth in metaphase. This agent may also interfere with amino acid, cyclic AMP. and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. A vinca alkaloid related to VINBLASTINE that is used as a first-line treatment for NON-SMALL CELL LUNG CANCER, or for advanced or metastatic BREAST CANCER refractory to treatment with ANTHRACYCLINES. See also: Vinorelbine Tartrate (active moiety of). L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CA - Vinca alkaloids and analogues C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids A vinca alkaloid with a norvinblastine skeleton. C1907 - Drug, Natural Product

HeterophyllinB

C40H58N8O8 (778.4377)

Heterophyllin B is a natural product found in Pseudostellaria heterophylla with data available. Heterophyllin B is an active cyclic peptide isolated from Pseudostellaria heterophylla. Heterophyllin B provides a novel strategy for the treatment of esophageal cancer[1]. Heterophyllin B is an active cyclic peptide isolated from Pseudostellaria heterophylla. Heterophyllin B provides a novel strategy for the treatment of esophageal cancer[1].

Heterophyllin

C40H58N8O8 (778.4377)

Heterophyllin B is a natural product found in Pseudostellaria heterophylla with data available. Heterophyllin B is an active cyclic peptide isolated from Pseudostellaria heterophylla. Heterophyllin B provides a novel strategy for the treatment of esophageal cancer[1]. Heterophyllin B is an active cyclic peptide isolated from Pseudostellaria heterophylla. Heterophyllin B provides a novel strategy for the treatment of esophageal cancer[1].

Sublanceoside E4

C41H62O14 (778.4139)

Antibiotic A 40A

C44H62N2O10 (778.4404)

Sublanceoside G3

C41H62O14 (778.4139)

Withanamide A

C40H62N2O13 (778.4252)

Stauntoside B

C40H58O15 (778.3776)

Clibadiolide

C44H58O12 (778.3928)

Kalidiumoside C

C41H62O14 (778.4139)

Fargoside D

C41H62O14 (778.4139)

Conophyllidine

C44H50N4O9 (778.3578)

16-hydroxy-3beta-O-[beta-D-xylopyranosyl-(1->3)-beta-D-glucopyranosyloxyuronic acid]-5alpha,14beta-poriferasta-7,16-diene-15,23-dione methyl ester|pandaroside G methyl ester

C41H62O14 (778.4139)

Araboglycyrrhizin

C41H62O14 (778.4139)

C43H54O13

C43H54O13 (778.3564)

MS000078713

C40H58N8O8 (778.4377)

amplexicoside A|glaucogenin C 3-O-beta-D-oleandropyranosyl-(1->4)-beta-D-3-demethyl-2-deoxythevetopyranosyl-(1->4)-beta-D-oleandropyranoside

C41H62O14 (778.4139)

C34H54N10O11

C34H54N10O11 (778.3973)

C41H62O14

C41H62O14 (778.4139)

C45H62O11

C45H62O11 (778.4292)

3beta,23-dihydroxy-30-norolean-12,20(29)-dien-28-oic acid 3-O-methyl beta-D-glucopyranosyluronate-(1->3)-alpha-L-arabinopyranoside|fargoside D

C41H62O14 (778.4139)

Pfaffoside C

C41H62O14 (778.4139)

disorazole B2

C42H54N2O12 (778.3677)

deoxyamplexicogenin A 3-O-beta-D-cymaropyranosoyl-(1?4)-beta-D-digitoxopyranosoyl-(1?4)-beta-D-thevetopyranoside|stauntoside J

C41H62O14 (778.4139)

3-(O-beta-D-glucopyranosyl(1?3)-alpha-L-arabinopyranosyl)-urs-12,18-diene-24,28-dioic acid|ilexsaponin E

C41H62O14 (778.4139)

trigothysoid P

C44H58O12 (778.3928)

goshonoside-G

C37H62O17 (778.3987)

Factumycin

C44H62N2O10 (778.4404)

9,10-seco-cycloarta-1(10),7,9-trien-3beta,24zeta,25-triol-16,23-dione 3-O-beta-D-xylopyranosyl-25-O-beta-D-glucopyranoside|foetidinoside B

C41H62O14 (778.4139)

Apioglycyrrhizin

C41H62O14 (778.4139)

C40H58O15

C40H58O15 (778.3776)

Vinorelbine (Navelbine)

C45H54N4O8 (778.3941)

NCGC00381134-01!

C43H54O13 (778.3564)

[IIN-based: Match]

C43H54O13 (778.3564)

[IIN-based on: CCMSLIB00000846922]

C43H54O13 (778.3564)

Periandrin V

C41H62O14 (778.4139)

(DHQ)2PHAL

C48H54N6O4 (778.4206)

(DHQD)2PHAL

C48H54N6O4 (778.4206)

AD-MIX-BETA

C48H54N6O4 (778.4206)

4-[4-[4-[2-[4-[2-[4-(diethylamino)phenyl]quinazolin-4-yl]oxyphenyl]propan-2-yl]phenoxy]quinazolin-2-yl]-N,N-diethylaniline

C51H50N6O2 (778.3995)

Withalongolide H

C40H58O15 (778.3776)

A withanolide saponin that consists of withaferin A attached to a alpha-L-rhamnopyranosyl(1->4)-beta-D-glucopyranosyl residue via a glycosidic linkage. Isolated from the aerial parts of Physalis longifolia, it exhibits antineoplastic activity.

Methyl (1R,10S,11R,19R)-11-acetyloxy-12-ethyl-4-[(12R,13S,14S)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate

C45H54N4O8 (778.3941)

methyl (1R,9R,10S,11R,12S,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

C45H54N4O8 (778.3941)

an archaeal dolichyl beta-D-glucuronosyl-(1->4)-alpha-D-glucosyl phosphate

C37H63O15P-2 (778.3904)

Alocrest

C45H54N4O8 (778.3941)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CA - Vinca alkaloids and analogues D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids

[(1S,2R,4S,5R,6S,7S,8R,9R,12R)-7,12-diacetyloxy-6-(acetyloxymethyl)-5-benzoyloxy-2,10,10-trimethyl-4-octanoyloxy-11-oxatricyclo[7.2.1.01,6]dodecan-8-yl] benzoate

C43H54O13 (778.3564)

[6-[2,3-bis[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy]propoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C41H62O12S (778.3962)

[(2R,3R,6R)-6-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C41H62O12S (778.3962)

[(2R,3R,6R)-6-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C41H62O12S (778.3962)

[(2R,3R,6R)-6-[2,3-bis[[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy]propoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C41H62O12S (778.3962)

LSM-4297

C45H54N4O8 (778.3941)

LSM-5284

C45H54N4O8 (778.3941)

LSM-6354

C45H54N4O8 (778.3941)

SMGDG O-32:9

C41H62O12S (778.3962)

SQDG 32:8

C41H62O12S (778.3962)

HBMP 36:7

C42H67O11P (778.4421)

PG 14:1/22:7;O

C42H67O11P (778.4421)

PG 22:5/13:4;O2

C41H63O12P (778.4057)

PG 22:6/13:3;O2

C41H63O12P (778.4057)

PG 35:9;O2

C41H63O12P (778.4057)

PG 36:8;O

C42H67O11P (778.4421)

LPIP 25:0

C34H68O15P2 (778.4033)

PI O-16:0/13:4;O2

C38H67O14P (778.4268)

PI O-20:0/9:4;O2

C38H67O14P (778.4268)

PI O-28:5;O3

C37H63O15P (778.3904)

PI O-29:4;O2

C38H67O14P (778.4268)

PI P-16:0/13:3;O2

C38H67O14P (778.4268)

PI P-16:1/12:3;O3

C37H63O15P (778.3904)

PI P-20:1/8:3;O3

C37H63O15P (778.3904)

PI 16:0/13:3;O

C38H67O14P (778.4268)

PI 16:1/12:3;O2

C37H63O15P (778.3904)

PI 18:1/11:2;O

C38H67O14P (778.4268)

PI 20:1/8:3;O2

C37H63O15P (778.3904)

PI 20:2/7:3;O3

C36H59O16P (778.3541)

PI 20:2/8:2;O2

C37H63O15P (778.3904)

PI 20:2/9:1;O

C38H67O14P (778.4268)

PI 20:3/7:2;O3

C36H59O16P (778.3541)

PI 20:3/8:1;O2

C37H63O15P (778.3904)

PI 22:0/7:3;O

C38H67O14P (778.4268)

PI 27:5;O3

C36H59O16P (778.3541)

PI 28:4;O2

C37H63O15P (778.3904)

PI 29:3;O

C38H67O14P (778.4268)

Angiotensin I/II (1-5) (TFA)

C32H49F3N8O11 (778.3473)

Angiotensin I/II 1-5 TFA is a peptide that contains the amino acids 1-5, which is converted from Angiotensin I/II. Angiotensin I is formed by the action of renin on angiotensinogen. Angiotensin II is produced from angiotensin I. Angiotensin I/II 1-5 TFA is an active mediator of renin-angiotensin system to stimulate atrial natriuretic peptide (ANP) secretion via Mas R and PI3K-Akt-NOS pathway.[1][2].

Angiotensin I/II (1-5) (TFA)

C32H49F3N8O11 (778.3473)

Angiotensin I/II 1-5 TFA is a peptide that contains the amino acids 1-5, which is converted from Angiotensin I/II. Angiotensin I is formed by the action of renin on angiotensinogen. Angiotensin II is produced from angiotensin I. Angiotensin I/II 1-5 TFA is an active mediator of renin-angiotensin system to stimulate atrial natriuretic peptide (ANP) secretion via Mas R and PI3K-Akt-NOS pathway.[1][2].

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-3,5-dihydroxy-4-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C41H62O14 (778.4139)

(1r,4r,5r,7r,8r,16s,19s,22r)-8-{[(2s,4s,5r,6r)-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxahexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-10,13-dien-7-ol

C41H62O14 (778.4139)

2,6-dihydroxy-7-{[5-({5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-4-methoxy-6-methyloxan-2-yl]oxy}-4b-methyl-2-(2-methylfuran-3-yl)-4,4a,5,6,7,8,10,10a-octahydro-3h-phenanthren-1-one

C41H62O14 (778.4139)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C41H62O14 (778.4139)

(3as,4s,5s,11ar)-6-formyl-4-{[2-(hydroxymethyl)prop-2-enoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-5-yl (2z,6z,10z)-12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoate

C44H58O12 (778.3928)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-(acetyloxy)-15-[(2r,3r,5s)-2-(acetyloxy)-5-[(1s)-1,2-bis(acetyloxy)-2-methylpropyl]oxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C45H62O11 (778.4292)

apioglycyrrhizin

C41H62O14 (778.4139)

{"Ingredient_id": "HBIN016489","Ingredient_name": "apioglycyrrhizin","Alias": "NA","Ingredient_formula": "C41H62O14","Ingredient_Smile": "CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(CO5)(CO)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C","Ingredient_weight": "778.92","OB_score": "17.80122953","CAS_id": "121709-66-8","SymMap_id": "SMIT06694","TCMID_id": "1519","TCMSP_id": "MOL004845","TCM_ID_id": "NA","PubChem_id": "101599071","DrugBank_id": "NA"}

apioglycyrrhizin_qt

C41H62O14 (778.4139)

{"Ingredient_id": "HBIN016490","Ingredient_name": "apioglycyrrhizin_qt","Alias": "NA","Ingredient_formula": "C41H62O14","Ingredient_Smile": "NA","Ingredient_weight": "778.92","OB_score": "23.72684537","CAS_id": "121709-66-8","SymMap_id": "SMIT06695","TCMID_id": "NA","TCMSP_id": "MOL004846","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

Araboglycyrrhizin

C41H62O14 (778.4139)

{"Ingredient_id": "HBIN016566","Ingredient_name": "Araboglycyrrhizin","Alias": "araboglycyrrhizin","Ingredient_formula": "C41H62O14","Ingredient_Smile": "CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(CO5)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C","Ingredient_weight": "778.92","OB_score": "17.73086814","CAS_id": "121687-83-0","SymMap_id": "SMIT06821","TCMID_id": "1597","TCMSP_id": "MOL004997","TCM_ID_id": "NA","PubChem_id": "101599072","DrugBank_id": "NA"}

8-{[5-({4-hydroxy-5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C41H62O14 (778.4139)

(2s,3s,4s,5r,6r)-6-{[(3s,4as,6ar,6br,8as,11s,12bs,14as,14bs)-11-carboxy-14b-formyl-4,4,6a,6b,8a,11-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl]oxy}-3,4-dihydroxy-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2-carboxylic acid

C41H62O14 (778.4139)

(6z,9z,17s)-17-hydroxy-n-[2-(5-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h-indol-3-yl)ethyl]octadeca-6,9-dienimidic acid

C40H62N2O13 (778.4252)

(4s)-4-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-1,3-dihydroxypropylidene]amino}-4-{[(1s)-1-{[(1s)-1-{[(1s)-4-carbamimidamido-1-{[(1s)-1-carboxy-2-phenylethyl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C34H54N10O11 (778.3973)

8-{[5-({4-hydroxy-5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxahexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-10,13-dien-7-ol

C41H62O14 (778.4139)

n-[(2e,4z,6r,7s,9s,10z,12e,14e,16e)-8,9-dihydroxy-18-(2-hydroxy-1-methyl-4-oxopyridin-3-yl)-6-methoxy-5,7,17-trimethyl-18-oxooctadeca-2,4,10,12,14,16-hexaen-1-yl]-2-[(2s,4s,6s)-2,4-dihydroxy-5,5-dimethyl-6-[(1e,3z)-penta-1,3-dien-1-yl]oxan-2-yl]butanimidic acid

C44H62N2O10 (778.4404)

(4s,5r,8s,13r,16s,19r,22r)-8-{[(2r,4r,5r,6r)-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C41H62O14 (778.4139)

methyl 6-{[1-(5-ethyl-6-methyl-4-oxoheptan-2-yl)-2-hydroxy-9a,11a-dimethyl-3-oxo-3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,5-dihydroxy-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxane-2-carboxylate

C41H62O14 (778.4139)

8,9,24,25-tetrahydroxy-4,20-bis(3-hydroxy-2-methylhex-4-en-2-yl)-3,15,19,31-tetraoxa-33,34-diazatricyclo[28.2.1.1¹⁴,¹⁷]tetratriaconta-1(32),6,10,12,14(34),16,22,26,28,30(33)-decaene-2,18-dione

C42H54N2O12 (778.3677)

(4s,5r,8s,13r,19r,22r)-8-{[(2r,4r,5r,6r)-5-{[(4s,5s,6r)-4-hydroxy-5-{[(4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C41H62O14 (778.4139)

(2s,3s,4s,5r,6r)-6-{[(1r,3as,5ar,5br,7ar,8s,9s,11ar,11br,13ar,13br)-3a-carboxy-8-formyl-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy}-3,4-dihydroxy-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2-carboxylic acid

C41H62O14 (778.4139)

(1z,4r,5r,8s,13r,16s,19s,22s)-8-{[(2s,4r,5s,6r)-4-hydroxy-5-{[(2s,4s,5r,6r)-4-hydroxy-5-{[(2s,4r,5r,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1,10-diene-14,21-dione

C40H58O15 (778.3776)

8-{[4-hydroxy-5-({4-hydroxy-5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1,10-diene-14,21-dione

C40H58O15 (778.3776)

6-formyl-4-{[2-(hydroxymethyl)prop-2-enoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-5-yl (2e,6z,10z)-12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoate

C44H58O12 (778.3928)

17-hydroxy-n-[2-(5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h-indol-3-yl)ethyl]octadeca-6,9-dienimidic acid

C40H62N2O13 (778.4252)

(3ar,4s,5r,11as)-6-formyl-4-{[2-(hydroxymethyl)prop-2-enoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-5-yl (2z,6z,10z)-12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoate

C44H58O12 (778.3928)

methyl (2s,3s,4s,5r,6r)-6-{[(3ar,5as,7s,9as,9br,11as)-1-[(2r,5r)-5-ethyl-6-methyl-4-oxoheptan-2-yl]-2-hydroxy-9a,11a-dimethyl-3-oxo-3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,5-dihydroxy-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2-carboxylate

C41H62O14 (778.4139)

(3s,9s,15s,24s,27s,30s)-24-benzyl-27-[(2s)-butan-2-yl]-17,20,23,26,29-pentahydroxy-15-(2-methylpropyl)-1,7,13,16,19,22,25,28-octaazatetracyclo[28.3.0.0³,⁷.0⁹,¹³]tritriaconta-16,19,22,25,28-pentaene-2,8,14-trione

C40H58N8O8 (778.4377)

15,26-dimethyl (2r,6s,13r,22r,23r,24r,35s,38s,39r)-13,24-diethyl-23,32-dihydroxy-30,31-dimethoxy-21-oxa-1,9,17,28-tetraazaundecacyclo[22.13.1.1⁶,⁹.0²,²².0³,²⁰.0⁵,¹⁸.0⁶,¹⁶.0²⁷,³⁵.0²⁹,³⁴.0³⁵,³⁸.0¹³,³⁹]nonatriaconta-3(20),4,11,15,18,26,29(34),30,32-nonaene-15,26-dicarboxylate

C44H50N4O9 (778.3578)

6-formyl-4-{[2-(hydroxymethyl)prop-2-enoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-5-yl 12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoate

C44H58O12 (778.3928)

(4s,5r,8s,13s,16s,19r,22r)-8-{[(2r,4r,5r,6r)-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C41H62O14 (778.4139)

24-benzyl-17,20,23,26,29-pentahydroxy-15-(2-methylpropyl)-27-(sec-butyl)-1,7,13,16,19,22,25,28-octaazatetracyclo[28.3.0.0³,⁷.0⁹,¹³]tritriaconta-16,19,22,25,28-pentaene-2,8,14-trione

C40H58N8O8 (778.4377)

(2s,4as,4br,6r,7r,10ar)-2,6-dihydroxy-7-{[(2s,4s,5r,6r)-5-{[(2s,4s,5r,6s)-5-{[(2s,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4b-methyl-2-(2-methylfuran-3-yl)-4,4a,5,6,7,8,10,10a-octahydro-3h-phenanthren-1-one

C41H62O14 (778.4139)

(4s,5r,8s,13s,16s,19r,22r)-8-{[(2r,4r,5r,6r)-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C41H62O14 (778.4139)

(1r,4r,5r,7s,8r,9r,10r,11s,12r)-10-[(3r,5s)-5-(acetyloxy)-3-(furan-3-yl)-2-methylcyclopent-1-en-1-yl]-9-(2-methoxy-2-oxoethyl)-4,8,10-trimethyl-5,7-bis({[(2e)-2-methylbut-2-enoyl]oxy})-2-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl (2e)-2-methylbut-2-enoate

C44H58O12 (778.3928)

(4s,5r,8s,13r,16s,19r,22r)-8-{[(2r,4r,5r,6r)-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C41H62O14 (778.4139)

(1e,4s,5r,8s,13r,16s,19r,22r)-8-{[(2r,4r,5s,6r)-4-hydroxy-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1,10-diene-14,21-dione

C40H58O15 (778.3776)

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,14b-pentamethyl-11-methylidene-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C41H62O14 (778.4139)

(2s,3s,4s,5r,6s)-6-{[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy}-5-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxyoxane-2-carboxylic acid

C41H62O14 (778.4139)

(2s,3s,4s,5r,6s)-6-{[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy}-3,4-dihydroxy-5-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2-carboxylic acid

C41H62O14 (778.4139)

6-{[4,4,6a,6b,14b-pentamethyl-11-methylidene-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C41H62O14 (778.4139)

(4r,6z,8r,9s,10e,12z,20r,22z,24r,25s,26e,28z)-8,9,24,25-tetrahydroxy-4,20-bis[(3s,4e)-3-hydroxy-2-methylhex-4-en-2-yl]-3,15,19,31-tetraoxa-33,34-diazatricyclo[28.2.1.1¹⁴,¹⁷]tetratriaconta-1(32),6,10,12,14(34),16,22,26,28,30(33)-decaene-2,18-dione

C42H54N2O12 (778.3677)

4-({2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-1,3-dihydroxypropylidene}amino)-4-[(1-{[1-({4-carbamimidamido-1-[(1-carboxy-2-phenylethyl)-c-hydroxycarbonimidoyl]butyl}-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]butanoic acid

C34H54N10O11 (778.3973)

(6z,10z,12z,22z,26z,28z)-8,9,24,25-tetrahydroxy-4,20-bis[(4e)-3-hydroxy-2-methylhex-4-en-2-yl]-3,15,19,31-tetraoxa-33,34-diazatricyclo[28.2.1.1¹⁴,¹⁷]tetratriaconta-1(32),6,10,12,14(34),16,22,26,28,30(33)-decaene-2,18-dione

C42H54N2O12 (778.3677)

4-methyl 8a-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-11-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}-4,6a,6b,11,14b-pentamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate

C41H62O14 (778.4139)

(4e,7s,8r,11s,16r,21s)-11-{[(2r,4r,5s,6r)-4-hydroxy-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-1,8-dimethyl-2,18,22-trioxapentacyclo[17.2.1.0⁴,²¹.0⁷,¹⁶.0⁸,¹³]docosa-4,13-diene-3,17-dione

C40H58O15 (778.3776)

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy}-3,4-dihydroxy-5-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2-carboxylic acid

C41H62O14 (778.4139)

(6z,9z,17r)-17-hydroxy-n-[2-(5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h-indol-3-yl)ethyl]octadeca-6,9-dienimidic acid

C40H62N2O13 (778.4252)

(2s,3s,4s,5r,6s)-6-{[(3s,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,14b-pentamethyl-11-methylidene-8a-({[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C41H62O14 (778.4139)

(4s,5r,8s,13r,16s,19r,22r)-8-{[(2r,4r,5r,6r)-5-{[(2s,4r,5s,6r)-4-hydroxy-5-{[(2s,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C41H62O14 (778.4139)

6-{[3a-carboxy-8-formyl-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy}-3,4-dihydroxy-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxane-2-carboxylic acid

C41H62O14 (778.4139)

n-[(2z,4e,10e,12z,14e,16e)-8,9-dihydroxy-18-(4-hydroxy-1-methyl-2-oxopyridin-3-yl)-6-methoxy-5,7,17-trimethyl-18-oxooctadeca-2,4,10,12,14,16-hexaen-1-yl]-2-{2,4-dihydroxy-5,5-dimethyl-6-[(1z,3e)-penta-1,3-dien-1-yl]oxan-2-yl}butanimidic acid

C44H62N2O10 (778.4404)

(4s,5r,8s,13r,16s,19r,22r)-8-{[(2r,4r,5r,6r)-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C41H62O14 (778.4139)

4-methyl 8a-(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3s,4s,4ar,6ar,6bs,8ar,11r,12as,14ar,14br)-3-hydroxy-11-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}-4,6a,6b,11,14b-pentamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate

C41H62O14 (778.4139)

15,26-dimethyl (2s,6r,13s,22r,23r,24r,35r,38s,39r)-13,24-diethyl-23,32-dihydroxy-30,31-dimethoxy-21-oxa-1,9,17,28-tetraazaundecacyclo[22.13.1.1⁶,⁹.0²,²².0³,²⁰.0⁵,¹⁸.0⁶,¹⁶.0²⁷,³⁵.0²⁹,³⁴.0³⁵,³⁸.0¹³,³⁹]nonatriaconta-3(20),4,11,15,18,26,29(34),30,32-nonaene-15,26-dicarboxylate

C44H50N4O9 (778.3578)

6-[(11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl)oxy]-3,4-dihydroxy-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxane-2-carboxylic acid

C41H62O14 (778.4139)

(2s,3s,4s,5r,6r)-3,5-dihydroxy-6-{[(1s,4s,5r,8r,10s,13r,14r,16s,17r)-16-hydroxy-4,5,9,9,13,20,20-heptamethyl-23-oxo-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-18-en-10-yl]oxy}-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2-carboxylic acid

C41H62O14 (778.4139)

3-(acetyloxy)-15-[2-(acetyloxy)-5-[1,2-bis(acetyloxy)-2-methylpropyl]oxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C45H62O11 (778.4292)

(1z,4s,5r,8s,13r,16s,19r,22r)-8-{[(2r,4r,5s,6r)-4-hydroxy-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1,10-diene-14,21-dione

C40H58O15 (778.3776)

(2s,4as,4br,6r,7r,10ar)-2,6-dihydroxy-7-{[(2s,4s,5r,6r)-5-{[(2s,4s,5r,6r)-5-{[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4b-methyl-2-(2-methylfuran-3-yl)-4,4a,5,6,7,8,10,10a-octahydro-3h-phenanthren-1-one

C41H62O14 (778.4139)